ARKG vs RSP
ARK Genomic Revolution ETF vs Invesco S&P 500 Equal Weight ETF
ARKG$47.17
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: 0.75%Yield: 0.00%
RSP$222.50
Invesco S&P 500 Equal Weight ETF
S&P 500 with each stock equally weighted.
Expense: 0.20%Yield: 1.46%
Quick take
- • RSP has the lower expense ratio at 0.20% vs 0.75% for ARKG.
- • RSP pays a higher dividend yield (1.46%).
Side-by-side metrics
| Metric | ARKG | RSP |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.20% |
Dividend yield Trailing 12-month yield. | 0.00% | 1.46% |
AUM Assets under management — bigger funds are typically more liquid. | $2.21B | $100.66B |
YTD return | 66.55% | 16.71% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.11 | 0.80 |
P/E ratio | — | 20.31 |
Last price | $47.17 | $222.50 |
Inception | — | — |
Issuer | ARK | Invesco |
ARKG top holdings
Top holdings · ARKG
| TWST | Twist Bioscience Corp | 8.75% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 8.73% |
| TEM | Tempus AI Inc Class A common stock | 8.36% |
| ABSI | Absci Corp | 5.56% |
| CRSP | CRISPR Therapeutics AG | 5.22% |
| GH | Guardant Health Inc | 4.88% |
| NTRA | Natera Inc | 4.71% |
| ILMN | Illumina Inc | 4.69% |
| LLY | Eli Lilly and Co | 3.92% |
| BEAM | Beam Therapeutics Inc | 3.69% |
Sector breakdown · ARKG
Healthcare100.0%
RSP top holdings
Top holdings · RSP
| MRNA | Moderna Inc | 0.32% |
| PTC | PTC Inc | 0.30% |
| ACN | Accenture PLC Class A | 0.29% |
| IT | Gartner Inc | 0.26% |
| HAS | Hasbro Inc | 0.26% |
| P | Everpure Inc Class A | 0.26% |
| MTD | Mettler-Toledo International Inc | 0.25% |
| CRL | Charles River Laboratories International Inc | 0.25% |
| CCL | Carnival Corporation Ltd | 0.25% |
| RVTY | Revvity Inc | 0.25% |
Sector breakdown · RSP
Real Estate5.8%
Consumer Cyclical11.1%
Basic Materials3.8%
Consumer Defensive6.6%
Technology16.9%
Communication Services3.4%
Financial Services13.9%
Utilities6.2%
Industrials15.1%
Energy4.3%
Healthcare12.9%
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $2.2B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 8.7% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About RSP
RSP (Invesco S&P 500 Equal Weight ETF) is S&P 500 with each stock equally weighted. Managed by Invesco, the fund carries $100.7B in assets under management, an expense ratio of 0.20%, a dividend yield of 1.46%. Its largest holding is Moderna Inc (MRNA), which represents 0.3% of the portfolio. Real Estate is the fund's largest sector exposure at 5.8%.